Copyright
©The Author(s) 2016.
World J Gastroenterol. Sep 7, 2016; 22(33): 7569-7578
Published online Sep 7, 2016. doi: 10.3748/wjg.v22.i33.7569
Published online Sep 7, 2016. doi: 10.3748/wjg.v22.i33.7569
Figure 3 Distribution of AKR1B10 expression levels in the study cohort.
Filled and blank patterns indicate patients with and without hepatocellular carcinoma development, respectively.
- Citation: Murata A, Genda T, Ichida T, Amano N, Sato S, Tsuzura H, Sato S, Narita Y, Kanemitsu Y, Shimada Y, Hirano K, Iijima K, Wada R, Nagahara A, Watanabe S. Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication. World J Gastroenterol 2016; 22(33): 7569-7578
- URL: https://www.wjgnet.com/1007-9327/full/v22/i33/7569.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i33.7569